Quest Diagnostics (DGX) Other Non-Current Liabilities: 2009-2025
Historic Other Non-Current Liabilities for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $982.0 million.
- Quest Diagnostics' Other Non-Current Liabilities rose 10.21% to $982.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $982.0 million, marking a year-over-year increase of 10.21%. This contributed to the annual value of $938.0 million for FY2024, which is 7.08% up from last year.
- Quest Diagnostics' Other Non-Current Liabilities amounted to $982.0 million in Q3 2025, which was up 10.34% from $890.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Other Non-Current Liabilities registered a high of $982.0 million during Q3 2025, and its lowest value of $728.0 million during Q2 2022.
- In the last 3 years, Quest Diagnostics' Other Non-Current Liabilities had a median value of $890.0 million in 2025 and averaged $882.4 million.
- In the last 5 years, Quest Diagnostics' Other Non-Current Liabilities decreased by 11.88% in 2022 and then climbed by 23.76% in 2023.
- Over the past 5 years, Quest Diagnostics' Other Non-Current Liabilities (Quarterly) stood at $792.0 million in 2021, then climbed by 2.53% to $812.0 million in 2022, then grew by 7.88% to $876.0 million in 2023, then increased by 7.08% to $938.0 million in 2024, then climbed by 10.21% to $982.0 million in 2025.
- Its Other Non-Current Liabilities was $982.0 million in Q3 2025, compared to $890.0 million in Q2 2025 and $917.0 million in Q1 2025.